In-Licensing Clinical Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
252
NCT06785636
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 7, 2025
Completion: Apr 30, 2029
Loading map...